Pfizer competitors

Pfizer Competitors include Johnson & Johnson, Novartis, Abbott, Roche, Baxalta and Eli Lilly.
Add company...
Pfizer
Pfizer
Pfizer is a biopharmaceutical company developing and manufacturing human and veterinary medicines, as well as consumer healthcare products.
Johnson & Johnson
Johnson & Johnson
Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Novartis
Novartis
Novartis researches, develops, manufactures, and markets a range of healthcare products.
Abbott
Abbott
Abbott is a genomic disease management company that develops and markets clinical laboratory products.
Roche
Roche
Roche Holding is a diagnostics and pharmaceutical company.
Baxalta
Baxalta
Baxalta Incorporated is a global biopharmaceutical company.
Eli Lilly
Eli Lilly
Eli Lilly and Company engages in the discovery, development, manufacture, and sale of products in pharmaceutical products business segment.
Founding Date
Founding Date
1849
Founding Date
1886
Founding Date
1996
Founding Date
1991
Founding Date
1896
Founding Date
2014
Founding Date
1876
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Subsidiary
Type
Public
Tags
Locations
Locations
New York, US HQ
Buenos Aires, AR
Melrose Park, AU
Wien, AT
Minsk, BY
Ixelles, BE
Sofia, BG
see more
Locations
New Brunswick, US HQ
Buenos Aires, AR
Yerevan, AM
Broadway, AU
Dhaka, BD
Minsk, BY
Machelen, BE
see more
Locations
Basel, CH HQ
Núñez, AR
Elsene, BE
São Paulo, BR
Dorval, CA
Chaoyang Qu, CN
Praha 4, CZ
see more
Locations
Illinois City, US HQ
Sao Paulo, BR
Québec, CA
Shanghai, CN
Beijing, CN
Wiesbaden, DE
Tokyo, JP
see more
Locations
Basel, CH HQ
South San Francisco, US
Locations
Illinois City, US HQ
Locations
Indianapolis, US HQ
Melrose Park, AU
Sydney, AU
Wien, AT
Toronto, CA
Charlottetown, CA
Dali, CN
see more
Employees
Employees
90,2007% decrease
Employees
134,000
Employees
126,0004% increase
Employees
99,000
Employees
93,734
Employees
N/A
Employees
38,1606% decrease
Valuation ($)
Valuation ($)
253.2 b
Valuation ($)
356.7 b
Valuation ($)
175.5 b
Valuation ($)
124.3 b
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
118.6 b
Twitter followers
Twitter followers
13.3 k
Twitter followers
90.5 k
Twitter followers
234.4 k
Twitter followers
61.1 k
Twitter followers
177.2 k
Twitter followers
N/A
Twitter followers
69

Financial

Revenue (est.)
Revenue (est.)
$52.5b (FY, 2017)
Revenue (est.)
$76.5b (FY, 2017)
Revenue (est.)
$49.1b (FY, 2017)
Revenue (est.)
$27.4b (FY, 2017)
Revenue (est.)
CHF48.1b (FY, 2015)
Revenue (est.)
N/A
Revenue (est.)
$21.2b (FY, 2016)
Cost of goods
Cost of goods
$11.2b (FY, 2017)
Cost of goods
$25.4b (FY, 2017)
Cost of goods
$17.2b (FY, 2017)
Cost of goods
$12.3b (FY, 2017)
Cost of goods
CHF15.5b (FY, 2015)
Cost of goods
N/A
Cost of goods
$5.7b (FY, 2016)
Gross profit
Gross profit
$41.3b (FY, 2017)
Gross profit
$51.1b (FY, 2017)
Gross profit
$31.9b (FY, 2017)
Gross profit
$15.1b (FY, 2017)
Gross profit
CHF32.7b (FY, 2015)
Gross profit
N/A
Gross profit
$15.6b (FY, 2016)
Net income
Net income
$21.3b (FY, 2017)
Net income
$1.3b (FY, 2017)
Net income
$7.7b (FY, 2017)
Net income
$477m (FY, 2017)
Net income
CHF9.1b (FY, 2015)
Net income
N/A
Net income
$2.7b (FY, 2016)

Operating

Countries
Countries
125 (FY, 2017)
Countries
60 (FY, 2017)
Countries
N/A
Countries
N/A
Countries
N/A
Countries
N/A
Countries
N/A
Discovery Projects
Discovery Projects
87 (FY, 2017)
Discovery Projects
150 (FY, 2015)
Discovery Projects
N/A
Discovery Projects
N/A
Discovery Projects
N/A
Discovery Projects
N/A
Discovery Projects
N/A
Drugs Approved by FDA
Drugs Approved by FDA
N/A
Drugs Approved by FDA
2 (FY, 2015)
Drugs Approved by FDA
N/A
Drugs Approved by FDA
N/A
Drugs Approved by FDA
2 (Y, 2015)
Drugs Approved by FDA
N/A
Drugs Approved by FDA
N/A
Major Approvals (US, EU, JP)
Major Approvals (US, EU, JP)
N/A
Major Approvals (US, EU, JP)
N/A
Major Approvals (US, EU, JP)
16 (Y, 2016)
Major Approvals (US, EU, JP)
N/A
Major Approvals (US, EU, JP)
12 (Y, 2016)
Major Approvals (US, EU, JP)
N/A
Major Approvals (US, EU, JP)
N/A
Phase III Trials Products
Phase III Trials Products
29 (FY, 2017)
Phase III Trials Products
N/A
Phase III Trials Products
29 (Y, 2016)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
19 (FY, 2016)
US FDA Breakthrough Therapy Designations
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
5 (Y, 2016)
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
5 (Y, 2016)
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 6.5m
Total funding raised
$ 6.8m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

Johnson & Johnson
HQ
New Brunswick, US
Employees
134,000

Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.

View company
Novartis
HQ
Basel, CH
Employees
126,000↑ 4% increase

Novartis researches, develops, manufactures, and markets a range of healthcare products.

View company
Abbott
HQ
Illinois City, US
Employees
99,000

Abbott is a genomic disease management company that develops and markets clinical laboratory products.

View company
Roche
HQ
Basel, CH
Employees
93,734

Roche Holding is a diagnostics and pharmaceutical company.

View company